Document is current
Any future updates will be listed below
-
Authors
Truhn, Daniel https://orcid.org/0000-0002-9605-0728
Kather, Jakob Nikolas https://orcid.org/0000-0002-3730-5348
- License Information
-
More Information
Article History
First Online: 23 March 2026
Competing interests
: J.N.K. declares ongoing consulting services for AstraZeneca and Bioptimus. He also holds shares in StratifAI, Synagen and Spira Labs; has received an institutional research grant from GSK and AstraZeneca; and has received honoraria from AstraZeneca, Bayer, Daiichi Sankyo, Eisai, Janssen, Merck, MSD, BMS, Roche, Pfizer and Fresenius. D.T. holds shares in StratifAI and Synagen. He has received honoraria from AstraZeneca, MSD, BMS, Roche, Pfizer and Gilead.
